Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density
...rzoxifene 1.1%; placebo, -1.1%, p<1.001). Arzoxifene significantly decreased biochemical marker of bone resorption C-terminal cross-linking telopeptide of type I collagen (CTX, arzoxifene -30.01 percent, placebo 3.79 percent; p<0.001); and biochemical marker of bone formation serum N-terminal prope...N-Telopeptide, Cross-Linked, Urine : ARUP Lab Tests
The wildcard symbol (*) can be used in place of letters or characters in query ... Can be in any position in the term and matches any number of characters. Examples: ...Growth Rate of Adolescent Females is Related to Urinary N-Telopeptide
An abstract from the SRS 2004 Annual Meeting on Urinary N-Telopeptide and its relationship ... Publications. Publications. AANS Research. AANS/CNS Joint Section ...Biochemical Markers of Bone Turnover Part I: Biochemistry and Variability
... phenylalanine-rich domains of the telopeptide region of the alpha-1 ... the unique ability to cleave both helical and telopeptide regions of collagen I. ...Normalization of N-telopeptide Associated with Improved Survival from ...
Researchers involved in a multicenter international trial have reported that ... These results were published in the July 1, 2008 issue of Cancer. ...Diastolic Heart Failure: Evidence of Increased Myocardial Collagen ...
... III (all P<0.001), carboxy-terminal telopeptide of procollagen type I(P=0.008) ... serum levels of carboxy-terminal telopeptide of collagen type I, and matrix ...